|
| Neurophilin1 in tumor growth |
|
https://doi.org/10.18632/oncotarget.734
Shailendra Kapoor
|
| 1259 |
|
| Tolllike receptor 2: therapeutic target for gastric carcinogenesis |
|
https://doi.org/10.18632/oncotarget.735
William McCormack, Masanobu Oshima, Patrick Tan, and Brendan J. Jenkins
|
| 1260-1261 |
|
| KRAS above and beyond – EGFR in pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.750
Jens T. Siveke, and Howard C. Crawford
|
| 1262-1263 |
|
| Epigenetics cMyc and Aggressive Bcell Lymphomas |
|
https://doi.org/10.18632/oncotarget.748
Yizhuo Zhang, Xiaohong Zhao, and Jianguo Tao
|
| 1264-1265 |
|
| Genetic Induction of the Warburg Effect Inhibits Tumor Growth |
|
https://doi.org/10.18632/oncotarget.739
Federica Sotgia, Ubaldo E. Martinez-Outschoorn, and Michael P. Lisanti
|
| 1266-1267 |
|
| miR150: targeting MLL leukemia |
|
https://doi.org/10.18632/oncotarget.736
Xi Jiang, and Jianjun Chen
|
| 1268-1269 |
|
| Immunosurveillance against cancerassociated hyperploidy |
|
https://doi.org/10.18632/oncotarget.753
Laura Senovilla, Lorenzo Galluzzi, Guillermo Mariño, Ilio Vitale, Maria Castedo, and Guido Kroemer
|
| 1270-1271 |
|
| NRF2 and p53: Januses in cancer |
|
https://doi.org/10.18632/oncotarget.754
Barak Rotblat, Gerry Melino, and Richard A. Knight
|
| 1272-1283 |
|
| Spliceosome mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia |
|
https://doi.org/10.18632/oncotarget.749
Virginie Chesnais, Olivier Kosmider, Frederik Damm, Raphael Itzykson, Olivier A Bernard, Eric Solary, and Michaela Fontenay
|
| 1284-1293 |
|
| Identification of acetylationdependent regulatory mechanisms that govern the oncogenic functions of Skp2 |
|
https://doi.org/10.18632/oncotarget.740
Zhiwei Wang, Hiroyuki Inuzuka, Jiateng Zhong, Pengda Liu, Fakul H Sarkar, Yi Sun, and Wenyi Wei
|
| 1294-1300 |
|
| The Interfaces Between Signal Transduction Pathways: IGF1/mTor p53 and the Parkinson Disease Pathway |
|
https://doi.org/10.18632/oncotarget.759
Arnold J. Levine, Chris R. Harris, and Anna M. Puzio-Kuter
|
| 1301-1307 |
|
| Recurrent targets of aberrant somatic hypermutation in lymphoma |
|
https://doi.org/10.18632/oncotarget.653
Alireza Hadj Khodabakhshi, Ryan D Morin, Anthony P Fejes, Andrew J Mungall, Karen L Mungall, Madison Bolger-Munro, Nathalie A Johnson, Joseph M Connors, Randy D Gascoyne, Marco A Marra, Inanc Birol, and Steven JM Jones
|
| 1308-1319 |
|
| Genes affected by mouse mammary tumor virus MMTV proviral insertions in mouse mammary tumors are deregulated or mutated in primary human mammary tumors |
|
https://doi.org/10.18632/oncotarget.682
Robert Callahan, Uma Mudunuri, Sharon Bargo, Ahmed Raafat, David McCurdy, Corinne Boulanger, William Lowther, Robert Stephens, Brian T. Luke, Claudia Stewart, Xiaolin Wu, David Munroe, and Gilbert H. Smith
|
| 1320-1334 |
|
| Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation Highlight of a putative therapeutic window in Multiple Myeloma |
|
https://doi.org/10.18632/oncotarget.650
Anouk Caraux, Laure Vincent, Salahedine Bouhya, Philippe Quittet, Jérôme Moreaux, Guilhem Requirand, Jean-Luc Veyrune, Gaëlle Olivier, Guillaume Cartron, Jean-François Rossi, and Bernard Klein
|
| 1335-1347 |
|
| Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN |
|
https://doi.org/10.18632/oncotarget.694
Andrew D Beggs, Enric Domingo, Megan McGregor, Mikael Presz, Elaine Johnstone, Rachel Midgley, David Kerr, Dahmane Oukrif, Marco Novelli, Muti Abulafi, Shirley V Hodgson, Wakkas Fadhil, Mohammed Ilyas, and Ian P Tomlinson
|
| 1348-1355 |
|
| Pyruvate kinase is a dosagedependent regulator of cellular amino acid homeostasis |
|
https://doi.org/10.18632/oncotarget.730
Katharina Bluemlein, Matthias Glueckmann, Nana-Maria Grüning, René Feichtinger, Antje Krüger, Mirjam MC. Wamelink, Hans Lehrach, Stephen Tate, Daniel Neureiter, Kofler Barbara, and Markus Ralser
|
| 1356-1369 |
|
| MicroRNA miR98 inhibits tumor angiogenesis and invasion by targeting activin receptorlike kinase4 and matrix metalloproteinase11 |
|
https://doi.org/10.18632/oncotarget.717
Vinayakumar Siragam, Zina Jeyapalan Rutnam, Weining Yang, Ling Fang, Linlin Luo, Xiangling Yan, Minhui Li, Zhaoqun Deng, Jun Qian, Chun Peng, and Burton B. Yang
|
| 1370-1385 |
|
| Tumor suppressive microRNA218 inhibits cancer cell migration and invasion through targeting laminin332 in head and neck squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.709
Takashi Kinoshita, Toyoyuki Hanazawa, Nijiro Nohata, Naoko Kikkawa, Hideki Enokida, Hirofumi Yoshino, Takeshi Yamasaki, Hideo Hidaka, Masayuki Nakagawa, Yoshitaka Okamoto, and Naohiko Seki
|
| 1386-1400 |
|
| Targeting MCT1 oncogene inhibits Shc pathway and xenograft tumorigenicity |
|
https://doi.org/10.18632/oncotarget.688
Hung-Ju Shih, Hsiao-Huei Chen, Yen-An Chen, Meng-Hsun Wu, Gan-Guang Liou, Wei-Wen Chang, Linyi Chen, Lu-Hai Wang, and Hsin-Ling Hsu
|
| 1401-1415 |
|
| Superior efficacy of cotreatment with dual PI3K/mTOR inhibitor NVPBEZ235 and panhistone deacetylase inhibitor against human pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.724
Sreedhar Venkannagari, Warren Fiskus, Karissa Peth, Peter Atadja, Manuel Hidalgo, Anirban Maitra, and Kapil N Bhalla
|
| 1416-1427 |
|
| Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in AfricanAmericans |
|
https://doi.org/10.18632/oncotarget.746
Kyle M. Walsh, Christopher I. Amos, Angela S. Wenzlaff, Ivan P. Gorlov, Jennette D. Sison, Xifeng Wu, Margaret R. Spitz, Helen M. Hansen, Emily Y. Lu, Chongjuan Wei, Huifeng Zhang, Wei Chen, Stacy M. Lloyd, Marsha L. Frazier, Paige M. Bracci, Michael F. Seldin, Margaret R. Wrensch, Ann G. Schwartz, and John K. Wiencke
|
| 1428-1438 |
|
| Epigenetic Regulation of miRNA211 by MMP9 Governs Glioma Cell Apoptosis Chemosensitivity and Radiosensitivity |
|
https://doi.org/10.18632/oncotarget.683
Swapna Asuthkar, Kiran Kumar Velpula, Chandramu Chetty, Bharathi Gorantla, and Jasti S. Rao
|
| 1439-1454 |
|
| Identification of miR30d as a novel prognostic maker of prostate cancer |
|
https://doi.org/10.18632/oncotarget.696
Naohito Kobayashi, Hiroji Uemura, Kiyotaka Nagahama, Koji Okudela, Mitsuko Furuya, Yoko Ino, Yusuke Ito, Hisashi Hirano, Yoshiaki Inayama, Ichiro Aoki, Yoji Nagashima, Yoshinobu Kubota, and Hitoshi Ishiguro
|
| 1455-1471 |
|
| Targeting HIF2α Translation with Tempol in VHLDeficient Clear Cell Renal Cell Carcinoma |
|
https://doi.org/10.18632/oncotarget.561
Carole Sourbier, Gaurav Srivastava, Manik C. Ghosh, Sanchari Ghosh, Youfeng Yang, Gopal Gupta, William DeGraff, Murali C. Krishna, James B. Mitchell, Tracey A. Rouault, and W. Marston Linehan
|
| 1472-1482 |
